
Claiming more than 150,000 lives each year, lung cancer is the deadliest cancer in the zzso zzso treatments in lung cancer include surgical zzso and chemotherapy, the latter of which offers only modest survival benefits at the expense of often severe and debilitating side zzso Recent advances in zzso the molecular biology of lung zzso have zzso novel drug targets, and treatments are rapidly evolving into specialized agents that zzso in on specific aspects of the zzso Of particular interest is blocking tumor growth by targeting the zzso processes surrounding zzso zzso growth factor zzso zzso zzso and other zzso signal zzso zzso This article looks at several areas of interest to lung cancer zzso and considers the current state of affairs surrounding the development of these zzso 

